A study of the trend in prevalence of opportunistic Candidal co-infections among patients of pulmonary tuberculosis

Pakistan Journal of Botany

Volumn 36, Issue 4, 2004, Pages 857-862

  Naz, Sehar Afshan ^a   Tariq, Perween ^a,b  

^a FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS;

EID: 14744271590     PISSN: 05563321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ahmed, Z., R. Bhargava, D.K. Pandey and K. Sharma. 2003. HIV seroprevalence in tuberculosis patients. Ind. J. Tub., 50: 151-154.
2. Barnes, A.J. and A.M. Wardley. 1996. Fatal Candida tropicalis fungaemia in leukaemic patients receiving fluconazole prophylaxis. J. Infect., 33: 43-45.
3. th Edition. Diagnostic Microbiology. The C.V. Mosby Company. 689-775.
4. Beck-Sagu'e, C.M. and W.R. Jarvis. 1993. National nosocomial infections surveillance system. Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980-1990. J. Infect. Dis., 167: 1247-51.
5. Blinkhom, R.J., D. Adelstein and P.J. Spagnulo. 1989. Emergence of a new opportunistic pathogen, Candida lustaniae. J. Clin. Microbiol., 27: 236-240.
6. Cheesbrough, M. 1994. Mycology. In: Medical Laboratory Manual For Tropical Countries. Tropical Health Technology/Butter Worth Heineman Ltd, ELBS Edition. 11: 372-391.
7. Chowdhary, A., K. Becker, W. Fegeler, H.C. Gugnani, L. Kapoor and V.S. Randhawa. 2003. An outbreak of Candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses, 46(8): 287-292.
8. Eggimann, P., J. Garbino and D. Pittet. 2003. Epidemiology of Candida species infections in critically ill non- immunosuppressed patients. Lancet Infect. Dis., 3(II): 685-702.
9. Ghafoor, M. 1967. Effect of the polysaccharide fraction of Candida albicans on the growth of Mycobacterium tuberculosis. Thesis. Jinnah Post Graduate Medical Centre, Karachi, Pakistan.
10. Hidalgo, J.A. and J.A. Vazquez. 2004. Candidiasis. e - Medicine Journal 2004 5(3).
11. Hsueh, P.R. and M.L. Chen. 2002. Antimicrobial drug resistance in pathogens causing nosocomial infections at a University Hospital in Taiwan 1981-1999. Emerg. Infect. Dis., 8(1).
12. Hube, B. and J. Naglik. 2001. Candida albicans proteinases : resolving the mystery of a gene family. Microbiol., 147: 1997-2005.
13. Jain, S.K., R.L. Agrawal and R.C. Pandey. 1991. A clinico- radiological study of secondary mycoses in pulmonary tuberculosis. Indian J. Med. Sci., 45(4): 81-84.
14. Jarvis, W.R. 1995. Epidemiology of nosocomial fungal infection with emphasis on Candida species. Clin. Infect. Dis., 20(6): 1525-1530.
15. th Edition, Appleton and Lange, Norwalk Connecticut/Los Altos, California, 318-337.
16. Khan, Z.U. and T.D. Chugh. 2000. Invasive fungal infections in Kuwait: A retrospective study. Indian J. Chest Dis. & Allied Sci., 42(4): 297-87.
17. Kim, S.J., Y.P. Hong and S.O. Kin. 1988. Fungal complications in patients with pulmonary tuberculosis or other lung disease. Korean J. Mycol., 16(1): 26-32.
18. Liv, Z.Y., R.Y. Sheng, X.L. Li, T.S. Li and A.X. Wang. 2003. Nosocomial fungal infections, analysis of 149 cases. Zhonghua Yi Xue Za Zhi., 83(5): 399-402.
19. Mankiewicz, E. 1954. Mycobacterium tuberculosis and Candida albicans: A study of growth promoting factor. Canad. J. Microbiol., 1: 85-89.
20. Mankiewicz, E. 1957. Candida albicans a mean for detecting M. tuberculosis on culture media. Am. Rev. Tuberc., 75: 836-840
21. Mankiewicz, E. and M. Liivak. 1960. Effect of Candida albicans on the evolution of experimental tuberculosis. Nature, 187: 250-251.
22. Mankiewicz, E., E. Stuckiewicz and M. Liivak. 1959. A polysaccharide isolated from Candida albicans as a growth promoting factor for Mycobacterium tuberculosis. Canad. J. Microbiol., 5(3): 261-267.
23. Murray, C.J.L. 1992. Draft trip report, Geneva. WHO, CDS.
24. Newman, S.L. and A. Holly. 2001. Candida albicans is phagocytosed, killed and processed for antigen presentation by human dendritic cells. Infect. & Immun., 69(II): 6813-6822.
25. Pfaller, M.A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis., 19 (Supp 1): S8-13.
26. Pukhlik, B.M., S.V. Zaikov and I.V. Kornitskaya. 1990. Sensitization to Candida fungi in patients with tuberculosis. Urach. Delo., 0(11): 22-24.
27. Randhawa, H.S. 2000. Respiratory and systemic mycoses: An overview. Indian J. Chest Dis. & Allied Sci., 42(4): 207-19.
28. Roilides, E., E. Farmaki, J. Evdoridou, A. Francesconi and M. Kasai. 2003. Candida tropicalis in a neonatal intensive care unit: Epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J. Clin. Microbiol., 41(2): 735-41.
29. Sain, D.O., S.S. Ginda and L.P. Ryvniak. 1991. Immunologic reactivity in patients with disseminated pulmonary tuberculosis with polysensitization. Probl. Tuberk., 6: 58-63.
30. Schell, W.A. 1995. New aspect of emerging fungal pathogen. A multifaceted challenge. In: Contemporary issues in clinical microbiology. (Ed.): J.D. Christic. Clin. Lab. Med., 15: 365-387.
31. Solov'eva, T.N., Z.O. Karaev, S.M. Ignateva and N. Mizonov. 1991. The diagnosis of mycotic infections in patients with respiratory tuberculosis. Probl. Tuberk., 7: 37-40.
32. Wenzel, R.P. 1995. Nosocomial Candidemia: Risk factors and attributable mortality. Clin. Infect. Dis., 20(6): 1531-1534.